Eshel brings a decade of experience in the Global Medical Cannabis field.
Having managed large scale medical Cannabis projects in the US and Israel, he was one of the first to enter the CBD Market back in 2017.
Heading the Global BD of his company he has created indication specific, EUGMP quality products that are known being sold in the EU, UK, Africa and Israel.
He brings vast experience in the field of global BD for the medical and wellness sectors of the industry.